Mercado mundial de stents vasculares: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado

La enfermedad arterial periférica (EAP) es el tipo más común de enfermedad vascular, caracterizada por la acumulación de placa en las arterias que transportan sangre desde el corazón al resto del cuerpo. La aterosclerosis es la causa más común de EAP en todo el mundo. El tabaquismo, la hipertensión arterial, la diabetes y el colesterol alto son factores de riesgo de EAP. La extremidad inferior es la ubicación más común de la enfermedad arterial periférica. El diagnóstico y el tratamiento de la EAP difieren de una persona a otra. La EAP se puede tratar quirúrgicamente o con procedimientos mínimamente invasivos. La forma de tratamiento más común y ampliamente aceptada para la EAP es el uso de stents vasculares.

Data Bridge Market Research analiza que se espera que el mercado de stents vasculares alcance un valor de USD 13,44 mil millones para el año 2029, con una CAGR del 7,81% durante el período de pronóstico.

Definición de mercado

Los stents vasculares son tubos de malla expandibles fabricados con acero inoxidable de grado médico o aleación de cobalto que se insertan en las arterias y venas bloqueadas para controlar el flujo sanguíneo. Son particularmente útiles para reducir el bloqueo y el estrechamiento recurrente de arterias y venas después de una angioplastia. Cuando se implantan stents en una arteria o vena, permanecen allí indefinidamente, lo que reduce en gran medida el riesgo de que se repita el estrechamiento.

Alcance del informe y segmentación del mercado

Vascular stent Market Dynamics

Drivers

• The increased demand for non-invasive surgical procedures

The growing global geriatric population, combined with an increase in demand for non-invasive surgical procedures, is broadening the scope of growth for the vascular stent market. Smoking, drinking alcohol, and eating unhealthy foods all contribute to the clogging or blocking of blood vessels

Low manufacturing costs

In the long run, this will increase demand for vascular stents. Other factors driving the growth of this market include a low risk-to-reward ratio and low manufacturing costs.

Regulatory Compliance

Maintaining compliance with medical reforms and diagnostics raises the demand for these solutions.

• Government investments for healthcare interoperability

The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the vascular stent market.

Opportunities

The strong trend of R&D investments in the biotechnology and pharmaceutical industries is also boosting market growth. Furthermore, rising per capita disposable income is one of the key factors fueling the growth of the vascular stent market.

Restraints/Challenges

However, stringent regulations imposed by the government to ensure patient safety will act as a significant market growth restraint. Furthermore, the high cost of undergoing the procedure will slow the market's growth rate even further.

This vascular stent market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vascular stent market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Vascular Stent Market

Over the last 18 months, almost every industry in the world has suffered a setback. This is due to significant disruptions in their respective manufacturing and supply-chain operations as a result of various precautionary lockdowns and other restrictions imposed by governing authorities around the world. The same can be said about the global Vascular Stent market. Furthermore, consumer demand has subsequently decreased as people are now more focused on eliminating non-essential expenses from their respective budgets as the general economic status of most people has been severely impacted by this outbreak. These factors are expected to weigh on the revenue trajectory of the global Vascular Stent market over the forecast period.

.Recent Development

• Medtronic's dominant position in the total bare-metal stent market stems from its strong presence in the market's high-value iliac and femoral-popliteal segments.
• With its VIABAHN® portfolio, W. L. Gore controls a sizable portion of the high-value covered stent segment. VIABAHN® devices are priced slightly higher than other covered stents on the market, such as iCast® and Fluency®.
• With its Express® LD iliac stent and Express® SD stents, Boston Scientific is a major player in the iliac and renal stent segments.

Global Vascular Stent Market Scope

The vascular stent market is segmented on the basis of type, product, mode of delivery, materials and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type                                                                                

• Drug-eluting stents
• Bare-metal stents
• Bio absorbable stents

On the basis of type, the global vascular stent market is segmented into drug-eluting stents, bare-metal stents and bio absorbable stents.

Product

• Coronary stents
• Peripheral stents
• Evar stent grafts

On the basis of product, the vascular stent market is segmented into coronary stents, peripheral stents and evar stent grafts. Peripheral stents are further bifurcated into carotid artery stents, renal artery stents, femoral artery stents, and iliac artery stents. Evar stent grafts are also further sub-segmented into abdominal aortic aneurysm stents and thoracic aortic aneurysm stents.

Mode of delivery

• Balloon-expandable stents
• Self-expanding stents

The vascular stent market can also be segmented on the basis of mode of delivery into balloon-expandable stents and self-expanding stents.

Materials

• Metallic stunts
• Other stunts

The vascular stent market is segmented on the basis of materials into metallic stents and other stents. Metallic stents are further bifurcated into cobalt chromium, platinum chromium, nickel titanium and stainless steel.

End User

• Hospitals and cardiac centres
• Ambulatory surgical centres
• Others

On the basis of end users, the vascular stent market is segmented into hospitals and cardiac centres, ambulatory surgical centres and others.

Vascular Stent Market Regional Analysis/Insights

The vascular stent market is analysed and market size insights and trends are provided by country, type, product, mode of delivery, materials and end user referenced above.

The countries covered in the vascular stent market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has dominated the market and will continue to do so during the forecast period due to the rapid increase in the adoption of minimal or non-invasive surgical procedures. Furthermore, the rapid advancement of technology is fueling this region's market share in the global vascular stent market. In contrast, Asia-Pacific is expected to grow at the fastest rate during the forecast period. The primary growth driver in this region is the growing geriatric population in need of medical care.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Puntos de datos como análisis de la cadena de valor aguas abajo y aguas arriba, tendencias técnicas y análisis de las cinco fuerzas de Porter, estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.   

Crecimiento de la infraestructura de salud Base instalada y penetración de nuevas tecnologías

El mercado de stents vasculares también le ofrece un análisis detallado del mercado para cada país: crecimiento del gasto sanitario en equipos de capital, base instalada de diferentes tipos de productos para el mercado de stents vasculares, impacto de la tecnología mediante curvas de línea de vida y cambios en los escenarios regulatorios de la atención médica y su impacto en el mercado de stents vasculares. Los datos están disponibles para el período histórico 2010-2020.

Análisis del panorama competitivo y de la cuota de mercado de los stents vasculares

El panorama competitivo del mercado de stents vasculares proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos, y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de stents vasculares.

Algunos de los principales actores que operan en el mercado de stents vasculares son

• Medtronic (Irlanda)
• BD. (Estados Unidos)
• Cordis. (Estados Unidos)
• Abbott. (Estados Unidos)
• Boston Scientific Corporation (Estados Unidos)
• Cocinero (Reino Unido,
• Cardiovascular Systems, Inc. (Estados Unidos)
• AngioDynamics. (Estados Unidos)
• Edwards Lifesciences Corporation (Estados Unidos)
• Biosensors International Group, Ltd. (Singapur)
• WL Gore & Associates, Inc. (Estados Unidos)
• Teleflex Incorporated. (Estados Unidos)
• Compañía Médica OrbusNeich Limited (Hong Kong)
• Sistemas médicos Merit (Estados Unidos)
• Corporación Médica Terumo (Japón)
• B. Braun Melsungen AG (Alemania)
• Corporación científica MicroPort (China)
• Tecnología Médica Lepu (Beijing) Co., Ltd (China)
• Koninklijke Philips NV (Países Bajos)

.

SKU-10106